Earnings Feed
Start Free
OSIRIS THERAPEUTICS, INC.·4

Mar 9, 4:00 PM ET

OSIRIS THERAPEUTICS, INC. 4

4 · OSIRIS THERAPEUTICS, INC. · Filed Mar 9, 2015

Insider Transaction Report

Form 4
Period: 2015-03-06
OSIRIS THERAPEUTICS, INC.OSIR
Debrabandere Lode
Vice President
Transactions
  • Award

    Incentive Stock Option (right to buy)

    2015-03-06$18.40/sh+5,434$99,986→ 377,934 total
    Exercise: $18.40From: 2016-03-06Exp: 2025-03-06→ Common Stock (5,434 underlying)
  • Award

    Non-Qualified Stock Option (right to buy)

    2015-03-06$18.40/sh+69,566$1,280,014→ 447,500 total
    Exercise: $18.40From: 2016-03-06Exp: 2025-03-06→ Common Stock (69,566 underlying)
Footnotes (1)
  • [F1]Options to purchase 75,000 shares of the common stock of the Registrant shall become exercisable with respect to the underlying shares as to 25% on each March 6, 2016, 2017, 2018 and 2019, assuming the Reporting Person continues to be employed by the Registrant on the vesting date.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -